114 related articles for article (PubMed ID: 38245444)
1. ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease.
Cao Z; Gao X; Meng J; Guo X; Xu J; Cui J; Zhou X
Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():38-46. PubMed ID: 38245444
[TBL] [Abstract][Full Text] [Related]
2. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
Hu Y; Tang W; Liu W; Hu Z; Pan C
Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
5. Nephropathy Is Aggravated by Fatty Acids in Diabetic Kidney Disease through Tubular Epithelial Cell Necroptosis and Is Alleviated by an RIPK-1 Inhibitor.
Yu Q; Chen Y; Zhao Y; Huang S; Xin X; Jiang L; Wang H; Wu W; Qu L; Xiang C; Wang S; Liu G; Yang L
Kidney Dis (Basel); 2023 Oct; 9(5):408-423. PubMed ID: 37927402
[TBL] [Abstract][Full Text] [Related]
6. IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease.
Xiong L; He T; Liu C; Qin S; Xiao T; Xin W; Wang Y; Ran L; Zhang B; Zhao J
Kidney Dis (Basel); 2023 Apr; 9(2):104-117. PubMed ID: 37065609
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy.
Chen Y; He L; Yang Y; Chen Y; Song Y; Lu X; Liang Y
Ren Fail; 2019 Nov; 41(1):821-831. PubMed ID: 31488013
[No Abstract] [Full Text] [Related]
8. Fatty acids and inflammatory stimuli induce expression of long-chain acyl-CoA synthetase 1 to promote lipid remodeling in diabetic kidney disease.
Wang CH; Surbhi ; Goraya S; Byun J; Pennathur S
J Biol Chem; 2024 Jan; 300(1):105502. PubMed ID: 38016515
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
[TBL] [Abstract][Full Text] [Related]
10. Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2/STAT3/SOCS1 pathway in streptozotocin-induced diabetic rats.
Zhu M; Wang H; Chen J; Zhu H
Life Sci; 2021 Jan; 265():118855. PubMed ID: 33278392
[TBL] [Abstract][Full Text] [Related]
11. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
Xu BH; Sheng J; You YK; Huang XR; Ma RCW; Wang Q; Lan HY
Metabolism; 2020 Feb; 103():154013. PubMed ID: 31734275
[TBL] [Abstract][Full Text] [Related]
13. SIRT3 Facilitates Amniotic Fluid Stem Cells to Repair Diabetic Nephropathy Through Protecting Mitochondrial Homeostasis by Modulation of Mitophagy.
Feng J; Lu C; Dai Q; Sheng J; Xu M
Cell Physiol Biochem; 2018; 46(4):1508-1524. PubMed ID: 29689547
[TBL] [Abstract][Full Text] [Related]
14. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
15. Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease.
Wang D; Yin L; Chen R; Tan W; Liang L; Xiang J; Zhang H; Zhou X; Deng H; Guo B; Wang Y
Front Med (Lausanne); 2022; 9():1018298. PubMed ID: 36760880
[TBL] [Abstract][Full Text] [Related]
16. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
Chang TT; Li SY; Lin LY; Chen C; Chen JW
Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
[TBL] [Abstract][Full Text] [Related]
17. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X
Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762
[TBL] [Abstract][Full Text] [Related]
18. Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7.
Gong M; Guo Y; Dong H; Wu W; Wu F; Lu F
Biomed Pharmacother; 2023 Dec; 168():115747. PubMed ID: 37864898
[TBL] [Abstract][Full Text] [Related]
19.
Yoon JJ; Park JH; Kim HJ; Jin HG; Kim HY; Ahn YM; Kim YC; Lee HS; Lee YJ; Kang DG
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30841605
[TBL] [Abstract][Full Text] [Related]
20.
Xu C; Chen Y; Liu Z; Fu X
Exp Ther Med; 2023 Oct; 26(4):493. PubMed ID: 37771649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
